Clinical Trial Update: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants [Phase 2]

View source ↗

Summary

Phase II clinical trial update for a live attenuated mumps vaccine (KMB-17) in Chinese infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mumps

Drugs mentioned

• Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) (null)

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: Epidemic Parotitis,Mumps | Phase 2 | Status: UNKNOWN